Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.
Treatment with antifungal drug amphotericin B is superior to itraconazole for HIV-associated talaromycosis.
Antiretroviral therapy may be the most consistent determinant of diabetes in patients with HIV.
A new study finds that not enough young MSM receive HIV testing despite accounting for most new diagnosis.
Financial incentives increase viral suppression in HIV-positive patients.
Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density.
Tenofovir gel reduced the incidence of HIV infection by 61% in women with Lactobacillus-dominant vaginal flora but only 18% in women with non-Lactobacillus bacteria, according to a new study.
Researchers determined the factors affecting health-related quality of life in military HIV patients.
New methods are available for reducing the risk of HIV transmission in HIV-discordant couples who would like to attempt conception.
Women with HIV are more likely to experience progressive cervical changes.
For patients with HCV and HIV coinfection, treatment is effective with standardized nurse/pharmacist support at urban clinics.
Gilead submitted their single-tablet regimen containing bictegravir, emtricitabine, and tenofovir alafenamide for HIV-1 treatment to the FDA.
The Food and Drug Administration has approved labeling updates for Prezcobix tablets for HIV.
Decreases were found in the prevalence of advanced disease at initiation of antiretroviral therapy (ART) in 10 high-burden countries.
The FDA approved higher dose of Isentress for the treatment of HIV-1 infection in adults and pediatric patients.
Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.
Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.
Norvir, an oral powder formulation to treat HIV-1 patients, has been approved by the FDA.
Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.
Long-term heavy nitrite inhalant use is associated with elevated risk of some virus-associated cancers.
More Americans with HIV are adhering to antiretroviral therapy regimens.
The FDA has approved the first generic version of Gilead's Truvada 200mg/300mg.
Antiretroviral therapy was found to be safe and clinically beneficial in young, postpartum women with high CD4+ T cell counts.
Free home-based HIV self-testing does not result in higher rates of testing.
Liver damage in patients with HIV and abdominal fat is linked to insulin resistance.
Researchers at Johns Hopkins were able to project yearly estimates of new HIV infections and forecast the route of HIV in the US.
Study looks at the decay of HIV viral load in the genital tract by comparing the effect of different drug families on treatment-naive HIV-infected patients.
Preventing the transmission of human immunodeficiency virus (HIV) is central to controlling the HIV epidemic in southern Africa. The PopART intervention program aimed to achieve high rates of universal testing and treatment using community-based health workers to conduct home visits in which they provided services such as HIV testing and referral to ART care.
ViiV Healthcare will discontinue Rescriptor Tablets for the treatment of HIV infection.
Exposure to highly active antiretroviral therapy, HAART, in adults with HIV increased patient's weight and related complications.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Antibiotic-Resistant Bacteria Have Long Resided on Ready-to-Eat Foods
- Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
- Tuberculosis Vaccine May Reverse Type 1 Diabetes
- No Benefits Seen for Adjunctive Clindamycin in Cellulitis
- Telbivudine During Early Pregnancy Prevents HBV Transmission
- Maternal Antibodies Hinder Antigenic Responses to Vaccines in Infants
- Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
- New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea
- Gut Microbiota Associated With Parkinson's Disease Progression
- Decrease Rate of S aureus Resistance Seen With Certain Antibiotics